Donepezil is not a cure for Donepezil is well tolerated; the most common adverse events are predictable from its cholinergic mechanism of action Lower incidence of adverse events in a naturalistic trial setting: It is available as round, film-coated tablets each containing donepezil hydrochloride 5 or 10 mg
Aricept (donepezil hydrochloride) is a cholinesterase inhibitor that reduces or prevents acetylcholine breakdown in brain tissue
Alzheimer dementia (moderate to severe): Oral: Patients stabilized on donepezil 10 mg once daily and not currently on memantine: Initial: Memantine extended release (ER) 7 mg/donepezil 10 mg once daily in the evening
Donepezil plasma concentration reaches its steady state within three months of treatment and remains unchanged
Maintenance dose: 23 mg orally once a day, after the patient has been on a dose of 10 mg once a day for at least 3 months
Urinary tract blockage or difficult urination—Donepezil may make these conditions worse
Read all information given to you
Donepezil hydrochloride, a piperidine derivative, is a centrally acting, rapid, reversible acetylcholinesterase inhibitor
Get donepezil for as low as $4
Current theories on the pathogenesis of the cognitive signs and symptoms of Alzheimer’s disease attribute some of them to a deficiency of cholinergic neurotransmission
You can take it with or without food
Donepezil hydrochloride may exaggerate succinylcholinetype muscle relaxation during - anaesthesia as it is a cholinesterase inhibitor
The potential risk for this action may be increased particularly in Drug Pharmacology and Mechanism of Action Receptors
1 It is a highly lipophilic synthetic phenylpiperidine opioid 1 that is structurally similar to